Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry

精神病学领域以患者为导向的综合指导研究培训 (IMPORT)

基本信息

  • 批准号:
    10627492
  • 负责人:
  • 金额:
    $ 20.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-01 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

SUMMARY Mental illness affects 15% of the population and creates enormous morbidity and cost. Physician-scientists have a critical role to play in advancing our understanding of its underlying pathophysiology and developing, refining, and deploying novel strategies for diagnosis, treatment, prevention, and cure. Yet the number of physician-scientists entering psychiatry remains distressingly limited – precisely when the science is advancing at an accelerating rate and new, science-grounded therapeutics are beginning to appear. This R25-funded training program, the Integrated Mentored Patient-Oriented Research Training (IMPORT) Program, has been training physician-scientist in the Yale psychiatry residency for 15 years. Its innovative design creates continuous, accelerated protected time for research, beginning in the first year of residency training and continuing through graduation. IMPORT trainees have gone on to faculty positions at top institutions, including leadership positions at major institutions. In this renewal application we build on this success, continuing the core training structure that has worked so well. We augment the training program in several important ways. First, we have enhanced our support for trainees from underrepresented backgrounds, recognizing that advancing the field requires not only recruitment of trainees with a diversity of backgrounds and perspectives, but also retention of these trainees through a network of supports. We have had considerable success in both recruitment and retention; we here apply the lessons learned from this experience. Second, we provide new training in scientific communication, so that our trainees will be positioned not only to create the innovations that will drive the field forward, but also to disseminate them to clinical providers and to the broader public. Third, we newly focus on participant-engaged research, which is increasingly recognized as critical both for the identification of the most impactful research questions and for the acceptance of new findings by at-risk populations. Finally, we reinforce our supports for grant-writing and career development, which are critical for the success of our trainees. Through these enhancements, we take the successful IMPORT program and improve it for the next generation. We are inspired by the success of this program over the past 15 years and energized to continue our support of psychiatric physician-scientists as we move into the next phase of this important training grant.
总结 精神疾病影响了15%的人口,并造成了巨大的发病率和成本。物理学家 在促进我们对其潜在病理生理学的理解和发展方面发挥着关键作用, 完善和部署新的诊断、治疗、预防和治愈策略。然而, 进入精神病学的医生-科学家仍然令人沮丧地受到限制-正是在科学进步的时候 新的、有科学依据的治疗方法开始出现。 这个R25资助的培训计划,综合辅导病人为导向的研究培训(IMPORT) 计划,一直在耶鲁大学精神病学住院医师培训医生科学家15年。其创新 设计创造了连续的,加速的研究保护时间,从居住的第一年开始 培训和继续通过毕业。IMPORT的受训人员已经走上了最高层的教职 机构,包括主要机构的领导职位。在此更新应用程序中,我们基于此 成功,继续运作良好的核心培训结构。我们增加了培训计划, 几个重要的方式。首先,我们加强了对代表性不足的学员的支持, 背景,认识到推进这一领域不仅需要招聘具有各种 背景和观点,而且还通过支持网络留住这些学员。我们有 在招聘和留住人才方面取得了相当大的成功;我们在此应用从中吸取的经验教训 体验.第二,我们提供新的科学交流培训,使我们的学员将 不仅能够创造创新,推动该领域的发展,而且还能够将其传播到 临床医生和广大公众。第三,我们新的重点是参与者参与的研究,这是 越来越多地被认为是确定最具影响力的研究问题和 高危人群对新发现的接受程度。最后,我们加强对赠款写作的支持, 职业发展,这对我们的学员的成功至关重要。 通过这些增强功能,我们将成功的IMPORT计划用于下一个 一代我们受到过去15年来该计划成功的鼓舞,并充满活力地继续下去 我们对精神科医生科学家的支持,因为我们进入了这个重要的培训补助金的下一阶段。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Stand By or Stand Up: Exploring the Biology of the Bystander Effect.
  • DOI:
    10.1016/j.biopsych.2021.05.007
  • 发表时间:
    2021-07-15
  • 期刊:
  • 影响因子:
    10.6
  • 作者:
    Scott ES;Ross DA;Fenstermacher E
  • 通讯作者:
    Fenstermacher E
Problems with the medicalization of marijuana.
大麻的医疗化问题。
  • DOI:
    10.1001/jama.2014.6175
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wilkinson,SamuelT;D'Souza,DeepakCyril
  • 通讯作者:
    D'Souza,DeepakCyril
Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes.
  • DOI:
    10.1080/15504263.2022.2053264
  • 发表时间:
    2022-04
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Selloni, Alexandria;Bhatia, Gagandeep;Ranganathan, Mohini;De Aquino, Joao P.
  • 通讯作者:
    De Aquino, Joao P.
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
  • DOI:
    10.1016/j.biopsych.2015.08.021
  • 发表时间:
    2016-06-15
  • 期刊:
  • 影响因子:
    10.6
  • 作者:
    Ranganathan M;Cortes-Briones J;Radhakrishnan R;Thurnauer H;Planeta B;Skosnik P;Gao H;Labaree D;Neumeister A;Pittman B;Surti T;Huang Y;Carson RE;D'Souza DC
  • 通讯作者:
    D'Souza DC
Any Questions? A Sober Look at MDMA.
  • DOI:
    10.1016/j.biopsych.2021.06.001
  • 发表时间:
    2021-08-01
  • 期刊:
  • 影响因子:
    10.6
  • 作者:
    Petry LG;Sharma M;Wolfgang AS;Ross DA;Cooper JJ
  • 通讯作者:
    Cooper JJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher John Pittenger其他文献

Christopher John Pittenger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher John Pittenger', 18)}}的其他基金

Examining individual differences in large scale brain networks in individuals with OCD and their relations to heterogeneity of obsessive compulsive symptoms.
检查强迫症患者大规模大脑网络的个体差异及其与强迫症状异质性的关系。
  • 批准号:
    10624934
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Anti-interneuron antibodies in rapid-onset pediatric OCD: clinical generalization and target identification
快速发作的儿科强迫症中的抗中间神经元抗体:临床概括和靶标识别
  • 批准号:
    10530955
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Dysregulation of dopamine receptors in the basal ganglia in OCD and tic disorders: Positron Emission Tomography with [11C]-PHNO
强迫症和抽动障碍中基底神经节多巴胺受体的失调:[11C]-PHNO 正电子发射断层扫描
  • 批准号:
    10672999
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Examining individual differences in large scale brain networks in individuals with OCD and their relations to heterogeneity of obsessive compulsive symptoms.
检查强迫症患者大规模大脑网络的个体差异及其与强迫症状异质性的关系。
  • 批准号:
    10527692
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Dysregulation of dopamine receptors in the basal ganglia in OCD and tic disorders: Positron Emission Tomography with [11C]-PHNO
强迫症和抽动障碍中基底神经节多巴胺受体的失调:[11C]-PHNO 正电子发射断层扫描
  • 批准号:
    10501537
  • 财政年份:
    2022
  • 资助金额:
    $ 20.32万
  • 项目类别:
Patient Oriented Research and Mentorship and Training in Functional Neuroimaging of Obsessive-Compulsive Disorder
强迫症功能神经影像以患者为导向的研究、指导和培训
  • 批准号:
    10314023
  • 财政年份:
    2020
  • 资助金额:
    $ 20.32万
  • 项目类别:
Patient Oriented Research and Mentorship and Training in Functional Neuroimaging of Obsessive-Compulsive Disorder
强迫症功能神经影像以患者为导向的研究、指导和培训
  • 批准号:
    10535440
  • 财政年份:
    2020
  • 资助金额:
    $ 20.32万
  • 项目类别:
Anti-interneuron antibodies in abrupt-onset pediatric obsessive-compulsive disorder
突发性小儿强迫症中的抗中间神经元抗体
  • 批准号:
    9916831
  • 财政年份:
    2019
  • 资助金额:
    $ 20.32万
  • 项目类别:
Evidence accumulation in obsessive-compulsive disorder during perceptual and value-based decisions
在基于知觉和价值的决策过程中强迫症的证据积累
  • 批准号:
    9755518
  • 财政年份:
    2018
  • 资助金额:
    $ 20.32万
  • 项目类别:
Histamine Regulation of the Basal Ganglia and the Pathophysiology of Tics
基底神经节的组胺调节和抽动的病理生理学
  • 批准号:
    9288634
  • 财政年份:
    2017
  • 资助金额:
    $ 20.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了